Shanghai Pharmaceuticals Holding Co Ltd Cash Flow-to-Debt Ratio
Shanghai Pharmaceuticals Holding Co Ltd cash flow-to-debt ratio. Shanghai Pharmaceuticals Holding Co Ltd (601607) has a Cash Flow-to-Debt Ratio of 0.01x as of September 2025, meaning its operating cash flow of CN¥1.56 Billion could theoretically repay 0% of its total liabilities (CN¥147.12 Billion) in one year. Check Shanghai Pharmaceuticals Holding Co Ltd (601607) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Shanghai Pharmaceuticals Holding Co Ltd (1998–2025)
Cash flow-to-debt ratio of Shanghai Pharmaceuticals Holding Co Ltd from 1998 to 2025. Historical debt coverage capacity for Shanghai Pharmaceuticals Holding Co Ltd across 28 annual periods. Check 601607 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Shanghai Pharmaceuticals Holding Co Ltd Cash Flow-to-Debt Ratio by Year (1998–2025)
Shanghai Pharmaceuticals Holding Co Ltd cash flow-to-debt ratio by year from 1998 to 2025. Year-by-year debt coverage analysis for Shanghai Pharmaceuticals Holding Co Ltd. For the full cash flow conversion analysis, see how efficiently does Shanghai Pharmaceuticals Holding Co Ltd generate cash.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.04x | CN¥6.15 Billion | CN¥143.36 Billion | ▲ +1.3% |
| 2024 | 0.04x | CN¥5.83 Billion | CN¥137.47 Billion | ▲ +6.7% |
| 2023 | 0.04x | CN¥5.23 Billion | CN¥131.65 Billion | ▲ +0.6% |
| 2022 | 0.04x | CN¥4.74 Billion | CN¥120.13 Billion | ▼ -18.6% |
| 2021 | 0.05x | CN¥5.06 Billion | CN¥104.37 Billion | ▼ -33.1% |
| 2020 | 0.07x | CN¥6.84 Billion | CN¥94.44 Billion | ▲ +5.5% |
| 2019 | 0.07x | CN¥6.02 Billion | CN¥87.64 Billion | ▲ +76.3% |
| 2018 | 0.04x | CN¥3.14 Billion | CN¥80.45 Billion | ▼ -19.6% |
| 2017 | 0.05x | CN¥2.65 Billion | CN¥54.67 Billion | ▲ +14.3% |
| 2016 | 0.04x | CN¥1.95 Billion | CN¥45.91 Billion | ▲ +27.4% |
| 2015 | 0.03x | CN¥1.35 Billion | CN¥40.54 Billion | ▼ -17.2% |
| 2014 | 0.04x | CN¥1.34 Billion | CN¥33.24 Billion | ▲ +12.7% |
| 2013 | 0.04x | CN¥973.45 Million | CN¥27.31 Billion | ▼ -27.6% |
| 2012 | 0.05x | CN¥1.15 Billion | CN¥23.37 Billion | ▼ -39.7% |
| 2011 | 0.08x | CN¥1.77 Billion | CN¥21.69 Billion | ▼ -21.1% |
| 2010 | 0.10x | CN¥1.69 Billion | CN¥16.28 Billion | ▼ -1.2% |
| 2009 | 0.10x | CN¥664.13 Million | CN¥6.33 Billion | ▲ +107.9% |
| 2008 | 0.05x | CN¥285.68 Million | CN¥5.67 Billion | ▼ -46.7% |
| 2007 | 0.09x | CN¥488.94 Million | CN¥5.17 Billion | ▼ -25.2% |
| 2006 | 0.13x | CN¥583.11 Million | CN¥4.61 Billion | ▲ +656.9% |
| 2005 | 0.02x | CN¥73.00 Million | CN¥4.37 Billion | ▲ +19.3% |
| 2004 | 0.01x | CN¥61.66 Million | CN¥4.40 Billion | ▲ +11546.7% |
| 2003 | 0.00x | CN¥484.27K | CN¥4.03 Billion | ▼ -99.6% |
| 2002 | 0.03x | CN¥100.84 Million | CN¥3.40 Billion | ▲ +11.6% |
| 2001 | 0.03x | CN¥65.73 Million | CN¥2.47 Billion | ▼ -53.7% |
| 2000 | 0.06x | CN¥146.22 Million | CN¥2.55 Billion | ▼ -23.2% |
| 1999 | 0.07x | CN¥164.67 Million | CN¥2.21 Billion | ▲ +150.0% |
| 1998 | -0.15x | CN¥-283.14 Million | CN¥1.90 Billion | — |